Article
<i>In vivo</i> inducible reverse genetics in patients’ tumors to identify individual therapeutic targets
2020-05-03
Abstract excerpt
High-throughput sequencing describes multiple alterations in each tumor (1), but their functional relevance is often unclear. Clinic-close, individualized molecular model systems are required for functional validation and to identify therapeutic targets of high significance for each patient (2). Here, we established a Cre-ER T 2 -loxP based inducible RNAi-mediated gene silencing system in patient-derived xenogra...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89340b04-76b3-5654-a70f-f2c1e09ba98d
- DOI
- 10.1101/2020.05.02.073577
